Subscribe to RSS
DOI: 10.1055/a-0586-8983
Clozapine-Induced DRESS Syndrome: A Case Series From the AMSP Multicenter Drug Safety Surveillance Project
Publication History
received
28 November 2017
revised
01 February 2018
accepted
28 February 2018
Publication Date:
19 March 2018 (online)
Abstract
Drug reaction with eosinophilia and systemic symptoms (DRESS) is an infrequent, but severe, adverse drug-induced reaction which occurs due to massive T-cell stimulation resulting in cytotoxicity and eosinophil activation and recruitment. The incidence is 0.4 cases per 100, 0000 in the general population; the mortality rate is up to 10%. Therefore, we believe that recognizing this syndrome is of particular importance. The problem we notice is that DRESS is often seen and described in patients receiving rheumatologic or anticonvulsant drugs, but very rarely in psychiatric hospitals, where Clozapine is frequently used, and that is the importance of this paper. DRESS Syndrome must be recognized promptly, and causative drugs withdrawn. Indeed, it has been reported that the earlier the drug withdrawal, the better the prognosis. In this paper, we present three cases of Clozapine-induced DRESS. All cases were recorded in the Multicenter Drug Safety Surveillance Project (AMSP).
-
References
- 1 Thongsri T, Chularojanamontri L, Pichler WJ. Cardiac involvement in DRESS syndrome. Asian Pac J Allergy Immunol 2017; 35: 3-10
- 2 Cacoub P, Musette P, Descamps V. et al The DRESS syndrome: A literature review. Am J Med 2011; 124: 588-597
- 3 Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur J Clin Pharmacol 2011; 67: 463-470
- 4 Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): A reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55: 1-8
- 5 Buck ML. DRESS syndrome: Examples from the pediatric literature. Pediatric Pharmacotherapy 2012; 18: 11
- 6 Ben-Ari K, Goldberg I, Shirazi I. et al. An unusual case of DRESS syndrome. Dermatol Case Rep 2008; 2: 39-42
- 7 Haack MJ, Bak ML, Beurrskens R. et al. Toxic rise of clozapine plasma concentrations in relation to inflammation. Euro Neuropsychopharmacol 2003; 13: 381-385
- 8 Santiago F, Goncalo M, Vieira R. et al. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 2010; 62: 47-53